Total Payments
$13,551
2024 Payments
$1,819
Companies
61
Transactions
1,128
Medicare Patients
4,032
Medicare Billing
$316,558
Payment Breakdown by Category
Food & Beverage$13,551 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,551 | 1,128 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,678 | 130 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,290 | 193 | $0 (2024) |
| GlaxoSmithKline, LLC. | $999.58 | 77 | $0 (2024) |
| Amgen Inc. | $846.10 | 59 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $796.11 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $747.15 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $661.98 | 50 | $0 (2022) |
| Novo Nordisk Inc | $632.64 | 76 | $0 (2024) |
| ABBVIE INC. | $582.72 | 36 | $0 (2024) |
| Lilly USA, LLC | $536.54 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,819 | 111 | GlaxoSmithKline, LLC. ($235.62) |
| 2023 | $608.15 | 32 | AbbVie Inc. ($188.90) |
| 2022 | $774.84 | 43 | Lilly USA, LLC ($135.87) |
| 2021 | $1,573 | 105 | Esperion Therapeutics, Inc. ($211.92) |
| 2020 | $1,369 | 107 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($178.70) |
| 2019 | $2,334 | 232 | Novartis Pharmaceuticals Corporation ($534.26) |
| 2018 | $2,510 | 252 | Novartis Pharmaceuticals Corporation ($359.58) |
| 2017 | $2,562 | 246 | Janssen Pharmaceuticals, Inc ($544.54) |
All Payment Transactions
1,128 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ANTIBIOTIC | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Obesity | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $48.05 | General |
| Category: Hematology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.73 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Hematology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Immunology | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.84 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: ANTIBIOTIC | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/20/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Hematology | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 534 | 977 | $153,857 | $62,128 |
| 2022 | 5 | 520 | 1,106 | $150,815 | $63,771 |
| 2021 | 4 | 564 | 1,175 | $148,592 | $68,325 |
| 2020 | 30 | 2,414 | 20,535 | $382,359 | $122,332 |
Total Patients
4,032
Total Services
23,793
Medicare Billing
$316,558
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 12 | 21 | $2,961 | $1,071 | 36.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2020 | 43 | 43 | $2,795 | $766.94 | 27.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 35 | 38 | $1,568 | $458.23 | 29.2% |
| 83540 | Iron level | Office | 2020 | 43 | 54 | $1,080 | $346.65 | 32.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 30 | 37 | $1,850 | $326.41 | 17.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 16 | 17 | $782.00 | $253.96 | 32.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2020 | 37 | 40 | $720.00 | $224.28 | 31.2% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2020 | 16 | 16 | $1,024 | $217.30 | 21.2% |
| 84439 | Thyroxine (thyroid chemical) measurement | Office | 2020 | 23 | 24 | $648.00 | $214.32 | 33.1% |
| 84153 | Psa (prostate specific antigen) measurement | Office | 2020 | 11 | 11 | $715.00 | $201.18 | 28.1% |
| 80048 | Blood test, basic group of blood chemicals | Office | 2020 | 23 | 23 | $598.00 | $192.37 | 32.2% |
| 83735 | Magnesium level | Office | 2020 | 23 | 25 | $500.00 | $166.07 | 33.2% |
| 82550 | Creatine kinase (cardiac enzyme) level | Office | 2020 | 19 | 23 | $460.00 | $148.95 | 32.4% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2020 | 27 | 29 | $464.00 | $148.92 | 32.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 13 | $468.00 | $129.22 | 27.6% |
| 82310 | Calcium level | Office | 2020 | 16 | 20 | $320.00 | $102.40 | 32.0% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation | Office | 2020 | 21 | 24 | $264.00 | $101.49 | 38.4% |
| 81001 | Manual urinalysis test with examination using microscope | Office | 2020 | 29 | 29 | $290.00 | $91.03 | 31.4% |
| 81002 | Urinalysis, manual test | Office | 2020 | 16 | 16 | $128.00 | $55.12 | 43.1% |
About Dr. Stephen Smith, MD
Dr. Stephen Smith, MD is a Internal Medicine healthcare provider based in Huntington, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417993486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Smith, MD has received a total of $13,551 in payments from pharmaceutical and medical device companies, with $1,819 received in 2024. These payments were reported across 1,128 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,551).
As a Medicare-enrolled provider, Smith has provided services to 4,032 Medicare beneficiaries, totaling 23,793 services with total Medicare billing of $316,558. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Huntington, WV
- Active Since 06/20/2006
- Last Updated 04/23/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417993486
Products in Payments
- ENTRESTO (Drug) $1,418
- XARELTO (Drug) $901.62
- ELIQUIS (Drug) $744.53
- TRELEGY ELLIPTA (Drug) $622.25
- JARDIANCE (Drug) $522.81
- NUEDEXTA (Drug) $502.54
- XIFAXAN (Drug) $484.68
- VRAYLAR (Drug) $419.55
- Ozempic (Drug) $390.22
- Vascepa (Drug) $352.88
- Aimovig (Biological) $341.73
- INVOKANA (Drug) $283.81
- NEXLETOL (Drug) $273.26
- LEQVIO (Drug) $260.75
- MOUNJARO (Drug) $240.99
- NURTEC ODT (Drug) $236.85
- LINZESS (Drug) $233.86
- FARXIGA (Drug) $232.17
- EVENITY (Biological) $195.79
- ACCRUFER (Drug) $191.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntington
Aamir Cheema, M.d, M.D
Internal Medicine — Payments: $207,509
Internal Medicine $207,509
Kofi Osei, Md, MD
Internal Medicine — Payments: $78,202
Internal Medicine $78,202
Wesam Frandah, Md, MD
Internal Medicine — Payments: $28,363
Internal Medicine $28,363
Murad Kheetan, Md, MD
Internal Medicine — Payments: $25,358
Internal Medicine $25,358
Rameez Sayyed, Md, MD
Internal Medicine — Payments: $24,444
Internal Medicine $24,444
David Patick, Md, MD
Internal Medicine — Payments: $23,768
Internal Medicine $23,768